Skip to main content

CORRECTION article

Front. Immunol., 04 January 2023
Sec. Alloimmunity and Transplantation

Corrigendum: Role of endothelial cells in graft-versus-host disease

  • 1Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, United States
  • 2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States
  • 3Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, Canada
  • 4Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States
  • 5Collège Bois de Boulogne, Montréal, QC, Canada
  • 6Centre de recherche de l’Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada

A corrigendum on
Role of endothelial cells in graft-versus-host disease

by Neidemire-Colley L, Robert J, Ackaoui A, Dorrance AM, Guimond M and Ranganathan P (2022) Front. Immunol. 13:1033490. doi: 10.3389/fimmu.2022.1033490

In the published article, there was an error regarding the affiliation(s) for Martin Guimond. As well as having affiliation 5, they should also have Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, Canada and Centre de recherche de l’Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: endothelial cell, endotheial dysfunction, GvHD, inflammation, integrins, selectins

Citation: Neidemire-Colley L, Robert J, Ackaoui A, Dorrance AM, Guimond M and Ranganathan P (2023) Corrigendum: Role of endothelial cells in graft-versus-host disease. Front. Immunol. 13:1125035. doi: 10.3389/fimmu.2022.1125035

Received: 15 December 2022; Accepted: 22 December 2022;
Published: 04 January 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Neidemire-Colley, Robert, Ackaoui, Dorrance, Guimond and Ranganathan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Parvathi Ranganathan, UGFydmF0aGkuUmFuZ2FuYXRoYW5Ab3N1bWMuZWR1

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.